These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 11085945)

  • 1. PrPSc-like prion protein peptide inhibits the function of cellular prion protein.
    Brown DR
    Biochem J; 2000 Dec; 352 Pt 2(Pt 2):511-8. PubMed ID: 11085945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prion protein peptides: optimal toxicity and peptide blockade of toxicity.
    Brown DR
    Mol Cell Neurosci; 2000 Jan; 15(1):66-78. PubMed ID: 10662506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiprion properties of prion protein-derived cell-penetrating peptides.
    Löfgren K; Wahlström A; Lundberg P; Langel U; Gräslund A; Bedecs K
    FASEB J; 2008 Jul; 22(7):2177-84. PubMed ID: 18296502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient inhibition of prion replication by PrP-Fc(2) suggests that the prion is a PrP(Sc) oligomer.
    Masel J; Genoud N; Aguzzi A
    J Mol Biol; 2005 Feb; 345(5):1243-51. PubMed ID: 15644218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Curative properties of antibodies against prion protein: a comparative in vitro study of monovalent fragments and divalent antibodies.
    Alexandrenne C; Hanoux V; Dkhissi F; Boquet D; Couraud JY; Wijkhuisen A
    J Neuroimmunol; 2009 Apr; 209(1-2):50-6. PubMed ID: 19232746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Copper binding to the neurotoxic peptide PrP106-126: thermodynamic and structural studies.
    Belosi B; Gaggelli E; Guerrini R; Kozłowski H; Łuczkowski M; Mancini FM; Remelli M; Valensin D; Valensin G
    Chembiochem; 2004 Mar; 5(3):349-59. PubMed ID: 14997527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Both host prion protein 131-188 subregion and prion strain characteristics regulate glycoform of PrP Sc.
    Yokoyama T; Shimada K; Masujin K; Iwamaru Y; Imamura M; Ushiki YK; Kimura KM; Itohara S; Shinagawa M
    Arch Virol; 2007; 152(3):603-9. PubMed ID: 17106625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prion and doppel proteins bind to granule cells of the cerebellum.
    Legname G; Nelken P; Guan Z; Kanyo ZF; DeArmond SJ; Prusiner SB
    Proc Natl Acad Sci U S A; 2002 Dec; 99(25):16285-90. PubMed ID: 12446843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of microglia and host prion protein in neurotoxicity of a prion protein fragment.
    Brown DR; Schmidt B; Kretzschmar HA
    Nature; 1996 Mar; 380(6572):345-7. PubMed ID: 8598929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient in vitro amplification of a mouse-adapted scrapie prion protein.
    Murayama Y; Yoshioka M; Yokoyama T; Iwamaru Y; Imamura M; Masujin K; Yoshiba S; Mohri S
    Neurosci Lett; 2007 Feb; 413(3):270-3. PubMed ID: 17174030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prion protein and copper: a mysterious relationship].
    Rachidi W; Riondel J; McMahon HM; Favier A
    Pathol Biol (Paris); 2005 May; 53(4):244-50. PubMed ID: 15850959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered toxicity of the prion protein peptide PrP106-126 carrying the Ala(117)-->Val mutation.
    Brown DR
    Biochem J; 2000 Mar; 346 Pt 3(Pt 3):785-91. PubMed ID: 10698707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of monoclonal antibody that distinguishes PrPSc from PrPC and neutralizes prion infectivity.
    Horiuchi M; Karino A; Furuoka H; Ishiguro N; Kimura K; Shinagawa M
    Virology; 2009 Nov; 394(2):200-7. PubMed ID: 19766283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of RNAi-mediated prnp gene silencing in neuroblastoma cells permanently infected by prions: potentials and limitations.
    Kim Y; Han B; Titlow W; Mays CE; Kwon M; Ryou C
    Antiviral Res; 2009 Nov; 84(2):185-93. PubMed ID: 19748523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of bovine spongiform encephalopathy, ovine scrapie prion-related protein (PrPSc) and normal PrPc by monoclonal antibodies raised to copper-refolded prion protein.
    Thackray AM; Madec JY; Wong E; Morgan-Warren R; Brown DR; Baron T; Bujdoso R
    Biochem J; 2003 Feb; 370(Pt 1):81-90. PubMed ID: 12429022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prion protein structure and its relationships with pathogenesis].
    Muramoto T
    Rinsho Shinkeigaku; 2003 Nov; 43(11):813-6. PubMed ID: 15152472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prion-protein-specific aptamer reduces PrPSc formation.
    Proske D; Gilch S; Wopfner F; Schätzl HM; Winnacker EL; Famulok M
    Chembiochem; 2002 Aug; 3(8):717-25. PubMed ID: 12203970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Octapeptide repeat region of prion protein (PrP) is required at an early stage for production of abnormal prion protein in PrP-deficient neuronal cell line.
    Sakudo A; Wu G; Onodera T; Ikuta K
    Biochem Biophys Res Commun; 2008 Jan; 365(1):164-9. PubMed ID: 17981146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Follicular dendritic cell of the knock-in mouse provides a new bioassay for human prions.
    Kitamoto T; Mohri S; Ironside JW; Miyoshi I; Tanaka T; Kitamoto N; Itohara S; Kasai N; Katsuki M; Higuchi J; Muramoto T; Shin RW
    Biochem Biophys Res Commun; 2002 Jun; 294(2):280-6. PubMed ID: 12051707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding of neural cell adhesion molecules (N-CAMs) to the cellular prion protein.
    Schmitt-Ulms G; Legname G; Baldwin MA; Ball HL; Bradon N; Bosque PJ; Crossin KL; Edelman GM; DeArmond SJ; Cohen FE; Prusiner SB
    J Mol Biol; 2001 Dec; 314(5):1209-25. PubMed ID: 11743735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.